Skip to search formSkip to main contentSkip to account menu

Levodopa

Known as: beta-(3,4-Dihydroxyphenyl)-L-alanine, 3,4-Dihydroxy-L-phenylalanine, .beta.-(3,4-Dihydroxyphenyl)-L-alanine 
An amino acid precursor of dopamine with antiparkinsonian properties. Levodopa is a prodrug that is converted to dopamine by DOPA decarboxylase and… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
1986
Highly Cited
1986
Several molecular forms of human GH (hGH) are present in blood, but their individual regulation is largely unknown. To examine… 
1984
1984
The regional cerebral distribution of carbon-14 activity was studied using autoradiography following the intravenous… 
Highly Cited
1978
Highly Cited
1978
We examined the effect of L-dopa, after peripheral L-amino acid decarboxylase inhibition, on sympathetic nerve activity (SNA) and… 
Highly Cited
1976
Highly Cited
1976
Ovarian follicles of Xen opus laevis exposed to exogenous radioactive pregnenolone have been observed to synthesize radioactive… 
Highly Cited
1976
Highly Cited
1976
Inhibitors of dopaminergic neurotransmission, such as reserpine (RES), given alone or combined with alpha-methyl-p-tyrosine… 
1976
1976
Interest in possible neuroendocrine disturbances in endogenous depression is prompted by two lines of evidence: (1) clinical… 
Highly Cited
1972
Highly Cited
1972
ABSTRACT 500 μg of thyrotropin releasing hormone (TRH) was injected intravenously into eight Parkinsonian patients being treated… 
Highly Cited
1972
Highly Cited
1972
Fourteen patients with galactorrhea, elevated serum prolactin levels (10–1130 ng/ml), and decreased urinary excretion of… 
Highly Cited
1960
Highly Cited
1960
Using an enzyme preparation from rabbit kidney cortex, the amino acids 3,4-dihydroxyphenylalanine and 5-hydroxytryptophan were… 
Highly Cited
1960
Highly Cited
1960
RECENT investigations in our laboratories have shown that α-methyl-3,4-dihydroxy-DL-phenylalanine (α-methyl-dopa) is an effective…